Despite a tumultuous year, the Bay Area life sciences sector remains a stronghold, developers said this month.
In Q1 this year, Bay Area biotech companies reeled in $6.46B in venture capital financing, up from $4.44B in Q4, according to research from Kidder Mathews, which was tracking 3.1M SF of life sciences tenant requirements for the Bay Area by the beginning of this quarter.
For the full story, go to Bisnow.
© 2020 Bisnow. All rights reserved.